Search Results - "Galiano, M T"

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation by Yamamoto-Furusho, J K, Bosques-Padilla, F, de-Paula, J, Galiano, M T, Ibañez, P, Juliao, F, Kotze, P G, Rocha, J L, Steinwurz, F, Veitia, G, Zaltman, C

“…The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise…”
Get full text

Characterization of inflammatory bowel disease in Colombia: Results of a national register by Juliao-Baños, F, Puentes, F, López, R, Saffon, M A, Reyes, G, Parra, V, Galiano, M T, Barraza, M, Molano, J, Álvarez, E, Corrales, R, Vargas, L E, Gil, F, Álvarez, P, Limas, L, Prieto, R, Yance, P, Díaz, F, Bareño, J

“…To determine the clinical, sociodemographic, and treatment characteristics of inflammatory bowel disease (IBD) in a Colombian population register. A…”
Get full text

Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part) by Yamamoto-Furusho, J K, Bosques-Padilla, F, Daffra, P, De Paula, J A, Etchevers, J, Galiano, M T, Ibañez, P, Juliao, F, Kotze, P G, Marroquín de la Garza, J M, Monreal Robles, R, Rocha, J L, Steinwurz, F, Vázquez-Frías, R, Veitia, G, Zaltman, C

“…This is the first Latin American Consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) regarding special situations in patients with…”
Get full text

Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU by Yamamoto-Furusho, J.K., Andrade, D., Barahona, J., Bautista, S., Bosques-Padilla, F., de Paula, J., Galiano, M.T., Iade, B., Juliao-Baños, F., Otoya, G., Steinwurz, F., Torres, E., Veitia, G., Barreiro-de Acosta, M.

“…Inflammatory bowel disease (IBD) is a chronic and incurable entity. The aim of the Pan American Crohn's and Colitis Organisation (PANCCO) is to create…”
Get full text

Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population by Juliao-Baños, F., Grillo-Ardila, C.F., Alfaro, I., Andara-Ramírez, M.T., Avelar-Escobar, O., Barahona-Garrido, J., Bautista-Martínez, S., Bosques-Padilla, F.J., De Paula, J.A., Ernest-Suárez, K., Galiano, M.T., Iade-Vergara, B., Patricio-Ibañez, Jara-Alba, M.L., Kotze, P.G., Miranda-Ojeda, M.C., Ortuño-Escalante, R., Otoya- Moreno, G., Piñol-Jiménez, F.N., Ramos-Polo, I.C., Sambuelli, A., Toro, M., Torres, E.A., Veitia-Velásquez, G.R., Yamamoto-Furusho, J.K., Zaltman, C., Steinwurz, F., Vallejo-Ortega, M., Torres-Castillo, J.I., Hamon-Pinilla, C., Calderon-Franco, C.H., Escobar-Villegas, A.M.

“…Ulcerative colitis (US) is a chronic disease of unknown etiology. It is incurable and its clinical course is intermittent, characterized by periods of…”
Get full text

P735 Real-life experience with the use of Tofacitinib in Colombian patients with moderate to severe Ulcerative Colitis: a descriptive study by Parra Izquierdo, L V, Frías-Ordoñez, J, Márquez, J R, Juliao-Baños, F, Galindo, P, Cuadros, C, Rojas, C, Rojas, N, Ardila, O, Tovar-Fierro, G, García-Duperly, R, Gil Parada, F L, Imbeth Acosta, P L, Puentes, F E, Galiano de Sánchez, M T, Hani de Ardila, A, Flórez-Sarmiento, C

Get full text